title: Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.
abstract: In vitro studies were conducted to identify the hepatic enzyme(s) responsible for the oxidative metabolism of linezolid. In human liver microsomes, linezolid was oxidized to a single metabolite, hydroxylinezolid (M1). Formation of M1 was determined to be dependent upon microsomal protein and NADPH. Over a concentration range of 2 to 700 microM, the rate of M1 formation conformed to first-order (nonsaturable) kinetics. Application of conventional in vitro techniques were unable to identify the molecular origin of M1 based on the following experiments: a) inhibitor/substrates for various cytochrome P-450 (CYP) enzymes were unable to inhibit M1 formation; b) formation of M1 did not correlate (r(2) < 0.23) with any of the measured catalytic activities across a population of human livers (n = 14); c) M1 formation was not detectable in incubations using microsomes prepared from a baculovirus insect cell line expressing CYPs 1A1, 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4, 3A5, and 4A11. In addition, results obtained from an in vitro P-450 inhibition screen revealed that linezolid was devoid of any inhibitory activity toward the following CYP enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4). Additional in vitro studies excluded the possibility of flavin-containing monooxygenase and monoamine oxidase as potential enzymes responsible for metabolite formation. However, metabolite formation was found to be optimal under basic (pH 9.0) conditions, which suggests the potential involvement of either an uncharacterized P-450 enzyme or an alternative microsomal mediated oxidative pathway.
authors.affiliation: Drug Metabolism Research Pharmacia Corporation Kalamazoo, MI, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Wynalda
authors.forename: M J
authors.initials: MJ
authors.lastname: Hauer
authors.forename: L C
authors.initials: LC
authors.lastname: Wienkers
mesh_terms: D000081:Acetamides / Q000493:pharmacokinetics*; D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D002250:Carbon Radioisotopes; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006801:Humans; D000069349:Linezolid; D013058:Mass Spectrometry; D008861:Microsomes / Q000201:enzymology; D008862:Microsomes, Liver / Q000378:metabolism*; D010080:Oxazoles / Q000493:pharmacokinetics*; D023303:Oxazolidinones; D010084:Oxidation-Reduction
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D002250:Carbon Radioisotopes; D010080:Oxazoles; D023303:Oxazolidinones; D003577:Cytochrome P-450 Enzyme System; D000069349:Linezolid